AuguryA New Standard for Pharma Training: ACTO’s CxZone Wins Two Honors at 2025 Pharma Technology Awards
This article was written by the Augury Times
Quick wins that could reshape pharma training
In December 2025, ACTO announced that its CxZone platform received two distinctions at the Pharmaceutical Technology Excellence Awards. The ceremony, which honors new tools and ideas in pharma technology, singled out CxZone for its role in helping medical and commercial teams practice real-world conversations with patients and colleagues. For busy pharma professionals, the awards underline that simulation tools are moving from niche pilots into mainstream training programs.
What this means in plain terms: companies are now recognizing virtual role-play driven by artificial intelligence as a useful way to build skills without putting staff or patients at risk. The honors do not change CxZone’s product overnight, but they make it more likely that hospitals, drug companies and commercial teams will give the platform a closer look when planning training for the coming year.
What CxZone does and why it stands out
CxZone is a training platform that uses scripted role-play, real-time feedback and AI-generated responses to simulate conversations that healthcare professionals face every day. Learners enter a scenario — for example, explaining a treatment to a patient or handling a tricky call with a colleague — and interact with a virtual counterpart that adapts to their choices. Sessions are recorded and scored so trainees can review strengths and weak spots.
The platform is aimed squarely at pharmaceutical teams, medical science liaisons and field staff who need practice in communication, compliance and clinical conversations. What sets CxZone apart, according to user descriptions, is a mix of flexible scenario design, easy-to-use interfaces for trainers and analytics that highlight behavioral cues rather than only right-or-wrong answers. That combination makes the tool useful both for one-on-one coaching and for tracking progress across a whole team.
The awards, what they recognize and the field this year
CxZone took home two distinctions presented by a panel of industry judges who assess entries on originality, practical impact and technical quality. The awards program is known in the sector for spotlighting tools that can be put into use quickly and that solve clear problems for pharmaceutical firms and health systems. This year’s competition included other learning platforms, data tools and remote-monitoring solutions, but CxZone earned praise for bringing simulation and AI together in a way judges saw as directly useful to field teams.
Winning at this ceremony tends to open doors: buyers use the award list as a short menu of credible vendors, and the publicity can accelerate pilot programs. The distinctions do not equal regulatory approval or clinical endorsement, but they do signal peer recognition from technology and pharma experts.
Voices from the announcement and a bit of company background
In a statement after the awards, ACTO described the recognition as validation of its work to create realistic practice environments for healthcare staff. “We built CxZone so teams could train in safe, repeatable scenarios that reflect what happens in the field,” an ACTO spokesperson said. “These honors show that simulation and coaching can improve confidence and consistency across commercial and medical teams.”
The awards organizers praised entries that combined practical utility with technical polish. One juror noted that CxZone’s user-driven scenario creation and measurable coaching outcomes stood out among submissions. “We look for tools that scale and that trainers can start using without months of setup,” the juror said.
ACTO is a provider of training and engagement tools for the life sciences sector. Its portfolio includes simulation platforms, content services and coaching modules designed for sales and medical teams. The company has grown by working with pharma clients on targeted rollouts rather than trying to be an all-in-one learning vendor.
What this might mean for the wider pharma industry
The practical takeaway is straightforward: more firms will test AI-driven role-play as part of regular training. That can speed up onboarding, make coaching more consistent across regions and give managers better data on how teams perform in common scenarios. For small teams and companies, the main benefit is access to repeatable practice without organizing large live role-play sessions.
There are limits too. Simulations depend on the quality of scenarios and the accuracy of AI responses, so they work best alongside human coaching. Regulators and compliance officers will also expect clear records and guardrails before a tool is used in high-stakes training. Still, with these awards, CxZone has nudged the industry toward wider adoption. Expect to see more pilot programs, demo days and vendor partnerships over the next year as training budgets shift toward digital practice tools.
Photo: Галина Ласаева / Pexels
Sources